About
This forum is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in cytokine signalling. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of cytokines and cytokine signalling, and its implications for clinical practice.
The programmes are free from commercial bias, and feature leading experts sharing their knowledge and experience in the form of video tutorials.
Podcasts
Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab
Podcasts
Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA
Podcasts
Discussing RA: Real-world evaluation of JAKi efficacy, persistence, and cardiovascular safety in RA
Podcasts
Author Interview: Professor Filip Rob, 2025
Podcasts
Webinar Highlights: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs: Part 2
Podcasts
Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis
Podcasts
Discussing RA: Long-term management of elderly patients with RA treated with tocilizumab
Podcasts
Pathways Modulating IMIDs: Webinar Highlights Podcast
Podcasts
Discussing PsA: Comparative effectiveness of biologic and targeted therapies in PsA: Insights from PARWCH and KEEPsAKE studies
Podcasts
Author Interview: Doctor David Kellner, September 2025
Podcasts
Discussing RA: Safety and vaccine immunogenicity of upadacitinib across immune-mediated diseases
Podcasts
Discussing RA: Efficacy and safety of upadacitinib for immune-mediated inflammatory disease patients
Podcasts
Discussing axSpA: Comparative real-world effectiveness of biologic and targeted therapies in axSpA
Podcasts
Author Interview: Doctor Rodrigo Garcia‑Salinas, August 2025
Podcasts
Discussing RA: Comparative outcomes of JAK inhibition and TNF blockade vs dual JAK–ROCK targeting
Podcasts
Author Interview: Doctor Martin Schaefer and Professor Anja Strangfeld, July 2025
Podcasts
Discussing PsA: Post hoc analyses on secukinumab and deucravacitinib from Phase 2 and 3 trials
Podcasts
Difficult-to-treat disease in Rheumatology Podcast Professors Iain McInnes and Peter Nash
Podcasts
Discussing axSpA: Secukinumab treatment outcomes on sustained remission and skeletal health in axSpA
Podcasts
Discussing RA: Impact of TOF on BMI, UPA monotherapy in MTX-IRs, and JAKis vs TNFis treatment
Podcasts
Podcast: AuToDeCRA, June 2025
Podcasts
Discussing PsA: Real-world data on biologic switching and the development of EMMs
Podcasts
Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA
Podcasts
Webinar Highlights Podcast: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs
Podcasts
Author Interview: Dr Saqr Alsakarneh, May 2025
Podcasts
Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA
Podcasts
Discussing RA: MACE, VTE, and malignancy in filgotinib RA and UC patients, and MACE related to JAKis
Podcasts
Webinar Highlights Podcast: IL-17 Inhibition: Controlling inflammation and disease progression in SpA
Podcasts
Discussing PsA: JAKi Comparative safety and Burden and determinants of multi‑b/tsDMARD failure in PsA
Podcasts
Discussing RA: Pain reduction & choosing second-line DMARDs after unresponsive first-line DMARDs
Podcasts
Author Interview: Professor Phillip Helliwell, March 2025
Podcasts